ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹193 Cr | ₹-725 Cr | ₹-194 Cr | ₹19 Cr | ₹2,854 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-725 Cr |
Mar2022 | ₹-194 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹2,854 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-725 Cr | Negative | |
Mar2022 | ₹-194 Cr | Negative | |
Mar2021 | ₹19 Cr | -99.32 | |
Mar2020 | ₹2,854 Cr | - |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹97,465.6 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹106,527.0 Cr | -2.8% | -0.7% | 52% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -3.6% |
-8.4% |
62.9% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses